神經(jīng)型一氧化氮合酶(NOS1)重組蛋白
Recombinant Nitric Oxide Synthase 1, Neuronal (NOS1)
NOS; nNOS; IHPS1; NC-NOS; N-NOS; bNOS; Neuronal NOS; Constitutive NOS; NOS type I; Nitric Ocide Synthase; Peptidyl-cysteine S-nitrosylase NOS1
- 編號RPA815Mu03
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞膜
- 預(yù)測分子量16.8kDa
- 實(shí)際分子量18kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Phe691~Met826 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)7.9
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1085¥ 2712¥ 5424¥ 16272¥ 40680
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
SDS-PAGE圖
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA815Mu01 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA815Mu04 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA815Mu02 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA815Mu03 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA815Mu01 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA815Mu02 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA815Mu03 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA815Mu04 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA815Mu71 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| PLoS One | A Novel Mechanism of Formaldehyde Neurotoxicity: Inhibition of Hydrogen Sulfide Generation by Promoting Overproduction of Nitric Oxide[PubMed: 23359814] |
| J Endocrinol Invest.? | The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders[Pubmed:25245337] |
| Достижения фундаментальной, клинической медицины и фармации: материалы 72-й науч. сес. сотр. ун-та, 25-26 янв | Состояние эндотелиально-сосудистого фактора у беременных с артериальной гипертензией[handle:123] |
| Clinical Oral Investigations | Clinical antibacterial effectiveness and biocompatibility of gaseous ozone after incomplete caries removal[Pubmed:29858659] |
| Journal of Young Pharmacists | Antioxydant and Endotheliotropic Properties 4-Hydroxy-3, 5-Di-Tret-Butyl Cinnamic Acid under Conditions of Experimental Brain Ischemia[:] |
| The?Eurasian?Journal of Medicine | Tadalafil Preserves Penile Nitric Oxide Synthase from Detrimental Effect of Paroxetine in Rats[Doi: 10.5152/eurasianjmed.2018.18160] |
| Oxid Med Cell Longev | The Role of Reactive Oxygen Species and Nitric Oxide in the Inhibition of Trichophyton rubrum Growth by HaCaT Cells[Pubmed: 32104540] |
| Archives of Oral Biology | Mandibular lateral deviation induces alteration in vascular endothelial growth factor expression and oxidative stress/nitric oxide generation in rat condyle, synovial?…[Pubmed: 31734543] |
| Dovepress | Protective Effects of Rocuronium Bromide on Ischemia-Reperfusion Injury in Skeletal Muscle Induced by Tourniquet in Patients Undergoing Elective Unilateral Total?…[Pubmed: 32884241] |
| Clinical Oral Investigations | Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients[Pubmed:35426000] |